Furthermore, the isocitrate dehydrogenase (IDH) 1 and 2 wildtype glioblastoma patients in this Group 1 have worse overall survival than those IDH-wildtype glioblastoma patients represented in the region overlapping with the paired cohort (Group 2) (Figure 1B). Here, IDH3A is linked to glioblastoma.